We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1B
AUM Growth
-$153M
Cap. Flow
-$98.4M
Cap. Flow %
-9.83%
Top 10 Hldgs %
38.56%
Holding
347
New
24
Increased
109
Reduced
88
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Financials 9.92%
3 Healthcare 9.86%
4 Consumer Discretionary 9.76%
5 Industrials 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSLC icon
126
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.1B
$761K 0.08%
10,710
+1,900
+22% +$150K
GDO
127
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.1M
$750K 0.07%
67,300
+3,000
+5% +$40.6K
ENB icon
128
Enbridge
ENB
$119B
$745K 0.07%
20,093
DE icon
129
Deere & Co
DE
$160B
$735K 0.07%
2,200
RNP icon
130
Cohen & Steers REIT and Preferred and Income Fund
RNP
$982M
$725K 0.07%
37,400
+4,000
+12% +$91.4K
FLG
131
Flagstar Bank National Association
FLG
$5.93B
$711K 0.07%
27,767
+4,967
+22% +$146K
QQQ icon
132
Invesco QQQ Trust
QQQ
$453B
$709K 0.07%
2,652
-37
-1% -$11.2K
TER icon
133
Teradyne
TER
$57.6B
$692K 0.07%
9,207
+300
+3% +$27.4K
BMY icon
134
Bristol-Myers Squibb
BMY
$133B
$680K 0.07%
9,564
+738
+8% +$53.5K
XBI icon
135
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$664K 0.07%
8,369
PG icon
136
Procter & Gamble
PG
$336B
$644K 0.06%
5,099
+42
+0.8% +$5.97K
ELV icon
137
Elevance Health
ELV
$81.5B
$641K 0.06%
1,412
FRA icon
138
BlackRock Floating Rate Income Strategies Fund
FRA
$383M
$640K 0.06%
58,150
GWW icon
139
W.W. Grainger
GWW
$65.3B
$636K 0.06%
1,300
AFT
140
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$634K 0.06%
50,700
RAND icon
141
Rand Capital
RAND
$629K 0.06%
42,911
VWO icon
142
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$629K 0.06%
17,239
+3,028
+21% +$123K
C icon
143
Citigroup
C
$222B
$621K 0.06%
14,914
BSCM
144
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$617K 0.06%
29,153
-28,825
-50% -$611K
PPT
145
Franklin Premier Income Trust
PPT
$324M
$596K 0.06%
166,500
MS icon
146
Morgan Stanley
MS
$331B
$594K 0.06%
7,512
+17
+0.2% +$1.43K
MA icon
147
Mastercard
MA
$502B
$592K 0.06%
2,083
+4
+0.2% +$1.33K
YUMC icon
148
Yum China
YUMC
$16.5B
$576K 0.06%
12,168
BSJN
149
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$573K 0.06%
25,100
RTX icon
150
RTX Corp
RTX
$290B
$555K 0.06%
6,779
+2,808
+71% +$254K

Similar funds

Shufro Rose & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Shufro Rose & Co held 347 positions worth $1B, down 13% from $1.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co withdrew a net $98.4M in Q3 2022, closing 13 positions and reducing 88 holdings. Its most notable exit was Alleghany Corp, an estimated $8.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Shufro Rose & Co opened a new position in Neogen worth $351K.

  • Shufro Rose & Co's largest Q3 2022 buy was Neogen: 25,136 shares worth $351K.
  • Shufro Rose & Co added most to iShares iBonds Dec 2026 Term Corporate ETF in Q3 2022, an estimated $26.5M increase.
  • Shufro Rose & Co's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $58.8M.
  • Shufro Rose & Co fully exited Alleghany Corp in Q3 2022, selling an estimated $8.81M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1B portfolio in Q3 2022.
  • Shufro Rose & Co opened 24 new positions and closed 13 in Q3 2022.
  • Shufro Rose & Co's portfolio value fell 13% quarter-over-quarter to $1B.

Based on Shufro Rose & Co's 13F filing for Q3 2022, filed 24 Oct 2022.